Inclusion Criteria: Subject has diagnosis of RA or PsA and indicated for treatment with etanercept per the current label, based on history. - Subject is willing to self-inject per investigator judgement at screening. - Subject has no known history of tuberculosis.
- Exclusion Criteria: Latex allergy. - Subject has any active infection (including chronic or localized infections) for which anti-infectives were indicated within 4 weeks prior to first study dose of etanercept. - Subject had prosthetic joint infection within 5 years of screening or native joint infection within 1 year of screening. - Other criteria may apply.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01901185?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
